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A new plant lectin from elderberry (Sambucus nigra L.) bark, which was shown by 
immunochemical techniques to bind specifically to terminal Neu5Ac(a2-6)GaVGalNAc 
residues of glycoconjugates, was immobilized onto Sepharose 4B (SNA-Sepharose) and 
its carbohydrate binding properties was determined using a series of standard com- 
pounds. Oligosaccharides, glycopeptides, or glycoproteins containing terminal 
Neu5Ac(a2-G)Gal/GalNAc sequences bound to SNA-Sepharose and were eluted with 
50-100 mM lactose, whereas those with Neu5Ac(a2-3)GaVGalNAc failed to bind to this 
column. Furthermore, the SNA-Sepharose column was capable of resolving two oligo- 
saccharides/glycopeptides based on the number of NeuEiAc(cYB-6)Gal units present in 
each molecule. Application of this technique to two glycoproteins, fetuin and orosomucoid, 
revealed the presence of microheterogeneity. It was also shown that esterification of 
the carboxyl group of Neu5Ac units, or branching at the O-3 of the subterminal GalNAc 
(probably also Gal) destroyed the binding ability of the molecule. o 1987 Academic press, lnc. 
Sialylated glycoproteins, glycolipids, and 
oligosaccharides are widely distributed 
throughout the animal kingdom (1). These 
sialylated glycoconjugates function as cell 
surface receptors for bacteria, viruses, and 
mycoplasma (2-7), as antigenic immuno- 
determinants (8, 9), and also have been 
considered to serve as “anti-recognition 
markers” for the metabolic clearance sys- 
tem of serum components and of certain 
blood cells (10). Sialic acid is usually pres- 
ent as the nonreducing terminal sugar of 
carbohydrate chains, often linked to D-ga- 
lactose (Gal)’ or N-acetyl-D-galactosamine 
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of Health Grant GM 294’70. 
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glutinin; Con A, concanavalin A; Gal, galactose; 
GalNAc, N-acetylgalactosamine; Neu5Ac, N-acetyl- 
neuraminic acid. 
(GalNAc) residues through 2,3- or 2,6- 
linkages. These sialylated glycoconjugates 
or their partial degradation products, gly- 
copeptides and oligosaccharides, can be 
analyzed by the use of ion-exchange chro- 
matography, a technique which resolves 
based on the density of sialic acid residues 
in the molecule (11, 12). However, using 
this approach it is very difficult to separate 
molecules which carry a similar number of 
sialic acid groups differing only in their 
linkage (i.e., 2,3- or 2,6-). 
We recently discovered that a new plant 
lectin from elderberry (Sambucus nip-a L) 
bark (SNA) (13) specifically binds the 
Neu5Ac(a2-G)Gal/GalNAc sequence (14). 
The affinity of SNA for oligosaccharides 
containing this Neu5Ac(cr2-6)Gal sequence 
is 20-150 times greater than those with the 
Neu5Ac(a2-3)Gal sequence, and 1600- 
10,000 times greater than for Gal. Based 
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on these results, we speculated that SNA 
would be a useful tool for the separation 
of sialylated glycoconjugates based on the 
type and number of Neu5Ac-Gal/GalNAc 
sequences in the molecule. This report 
demonstrates the application of immobi- 
lized SNA for the fractionation of glyco- 
conjugates as well as affording further in- 
sight regarding the carbohydrate binding 
specificity of this unique lectin. 
MATERIALS AND METHODS 
SNA-Sephaw~~e. SNA was purified as previously 
described (13) and coupled to Sepharose 4B by the 
method of March et al. (15). Neu5Ac(cy2-6)lactose (final 
concentration, 0.2 mM) was added to the reaction mix- 
ture to protect the carbohydrate binding site. The final 
product contained approximately 1.2 mg SNA/ml of 
the gel. 
Oligosaocha~, glycopeptides, and glycqwrottins. 
Purified Neu5Ac(a2-3)lactose, Neu5Ac(cY2-G)lactose, 
and DSL were the gifts of Dr. V. Ginsburg of the Na- 
tional Institutes of Health. ‘H-labeled milk oligosac- 
charides, LSTa, LSTb, and LSTc, were supplied by Dr. 
K. Yamashita of Kobe University and also by Dr. D. 
Smith of Virginia Polytechnic Institute and State 
University. Porcine thyroglobulin oligosaccharides (a 
biantennary fraction and also a mixture of tri- and 
tetraantennary fractions), human transferrin bian- 
tennary glycopeptide, human fibrinogen biantennary 
glycopeptide, and bovine fetuin triantennary oligo- 
saccharide were the gifts of Dr. J. P. Carver of the 
University of Toronto. 
Ovine submaxillary mucin and antifreeze glycopro- 
tein carrying [“CjNeu5Ac(cu2-3)GalNAc and [‘“Cl- 
NeuSAc(u2-6)GalNAc were provided by Dr. C. Paulson 
of the University of California at Los Angeles. Fetuin 
was purchased from Grand Island Biological Co. and 
orosomucoid was obtained from Dr. G. W. Jourdian 
of the University of Michigan. Asialo derivatives of 
both fetuin and orosomucoid were obtained by heat- 
ing these glycoproteins in 0.1 N sulfuric acid for 1 h 
at 80°C. 
Labeling of oligosaccharides and glycopeptides. A 
small quantity of oligosaccharide (50-100 nmol) was 
reduced, at room temperature, with excess sodium 
borotritide (lo-50 times excess on molar bases) for 
several hours or overnight. After the decomposition 
of excess reagent with acetic acid, the reaction product 
was purified by gel filtration on Biogel P-2. Glycopep- 
tides were labeled by incubating with rC]acetic an- 
hydride for l-2 h in 0.5% NaHC08. Labeled glycopep- 
tides were also purified using the Biogel P-2 column. 
EsterQkation and sapon$catim of [*HjNeu5Ac(aZ- 
6)kctitoL ‘H-labeled Neu5Ac(cY2-6)lactitol was ester- 
ified using dimethylsulfoxide and methyl iodide ac- 
cording to the method of Handa et al (16). The product 
was purified by gel filtration on Biogel P-2. Radioactive 
and Neu5Ac-positive fractions were collected and 
passed through a column of Dowex I-X8 (acetate form) 
to remove any unesterified material. 
The ester was saponified by treatment with 0.1 N 
NaOH for 1 h at room temperature, and then passed 
successively through columns of Dowex 5OW-X8 (H+ 
form) and Dowex I-X8 (acetate form). Free acid was 
obtained by eluting the latter column with 4 N acetic 
acid. 
Afinity chromatography. Oligosaccharides, glyco- 
peptides (l-10 nmol, in 30-100 ~1 of distilled water or 
PBS), or glycoproteins (2 mg in 1 ml PBS) were applied 
to the SNA-Sepharose column (1.5 X 14 or 1 X 52 cm) 
followed by stepwise elution with PBS, PBS containing 
50 or 100 mM lactose, and 20 XnM ethylenediamine. 
Gradient elution with O-100 mM lactose also was used 
in some experiments. The flow rate was lo-15 ml/h. 
The longer column was used for the experiment shown 
in Fig. 4; the shorter column was used for all other 
experiments. Elution was monitored either by mea- 
suring radioactivity or by absorption at 230 nm. All 
experiments were performed at 4°C. 
RESULTS 
Interaction of sialylated milk oligosac- 
charides with SNA-Sepharose. Various sia- 
lylated oligosaccharides obtained from 
human and bovine milk were labeled by re- 
duction with sodium borotritide and the 
resulting [3H]oligosaccharide alditols were 
applied to the SNA-Sepharose column. The 
simplest oligosaccharide alcohol contain- 
ing the Neu5Ac(cY2-6)Gal sequence- 
Neu5Ac(a2-G)lactitol-bound tightly to the 
SNA-Sepharose and was eluted with 50 mM 
lactose (Fig. 1A). On the other hand, 
Neu5Ac((u2-3)lactitol passed through the 
same column with the void volume (Fig. 
1B). Analysis of commercial “Neu5Ac(a2- 
G)lactose,” after reduction with sodium 
borotritide, revealed the presence of both 
2,3- and 2,6-isomers. The results of the 
analysis of other milk oligosaccharides, 
LSTa, LSTb, LSTc, and DSL (Fig. 2; struc- 
tures are listed in Table I), showed that 
only LSTc, which carries one NeuEiAc(aB- 
6)Gal unit, bound to the SNA-Sepharose. 
Oligosaccharides which possess the Neu- 
5Ac(a2-3)Gal or Gal@l-3)meu5Ac(a2-6)]- 
GlcNAc sequences did not bind to this 
column. 
Interaction of glywpeptides and oligosac- 
charides obtained from glycoproteins with 
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FIG. 1. Elution profile of sialyllactose on SNA- 
Sepharose. (A) Pure Neu5Ac(cu2-6)lactose; (B) pure 
Neu5Ac(a2-3)lactose; (C) commercial “Neu5Ac(cY2- 
6)lactose.” Lac = 50 mM lactose in PBS. 
SNA-Sepharose. A series of sialylated gly- 
copeptides and oligosaccharides, which 
were labeled by acetylation of amino 
groups with [14C]acetic anhydride or by 
conversion to the corresponding alditol by 
reduction with sodium borotritide, also 
were applied to the SNA-Sepharose col- 
umn. All compounds which contained at 
least one NeuEiAc(aZ-6)Gal unit in the 
molecule bound firmly to the SNA-Sepha- 
rose (Fig. 3). Although the biantennary 
glycopeptides from human fibrinogen and 
porcine thyroglobulin, both of which carry 
a single Neu5Ac(a2-6)Gal unit, were eluted 
completely from the column with 50 mM 
lactose solution (Figs. 3A and B), the bian- 
tennary glycopeptide from human trans- 
ferrin and the bovine fetuin triantennary 
oligosaccharide, both of which contain two 
units of this sequence, bound more strongly 
to the column and showed a retarded peak 
and also an additional peak which was 
eluted with 20 MM ethylenediamine (Figs. 
3C and D). These results suggested the 
possible use of the SNA-Sepharose column 
for the separation of glycopeptides/oligo- 
Neu5Ac(a2-6)Gal units. Figure 4 shows the 
elution profile of a mixture of 3H-labeled 
porcine thyroglobulin biantennary oligo- 
saccharide (containing one Neu5Ac(a2- 
6)Gal) and 14C-labeled human transferrin 
biantennary glycopeptide (containing two 
Neu5Ac(cY2-6)Gal). The main fractions of 
the mixture of these compounds clearly 
were separated from each other by the use 
of a linear lactose gradient, although a 
shoulder on the peaks was observed for 
both of them. It is not clear whether these 
shoulder peaks suggest some heterogeneity 
of the samples used for this experiment or 
whether they originated from a “spill- 
over” effect in 3H and 14C counting. A sim- 
ilar experiment consisting of a mixture of 
14C-labeled human fibrinogen biantennary 
glycopeptide (one Neu5Ac(cu2-6)Gal) and 
3H-labeled bovine fetuin triantennary oli- 
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FIG. 2. Elution profile of milk oligosaccharides on 
SNA-Sepharose. (A) LSTa; (B) LSTb; (C) LSTc; (D) 
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FIG. 3. Elution profile of oligosaccharides and 
glycopeptides obtained from glycoprotein on SNA- 
Sepharose. (A) Human fibrinogen biantennary gly- 
copeptide; (B) porcine thyroglobulin biantennary oli- 
gosaccharide; (C) human transferrin biantennary 
glycopeptide; (D) bovine fetuin triantennary oligo- 
saccharide; (E) porcine thyroglobulin tri- and te- 
traantennary oligosaccharide. (See Table I for the 
structures.) EDA = 20 mM ethylene diamine. 
gosaccharide (approximately 40% of it 
contains two Neu5Ac(a2-6)Gal) showed a 
marked retardation of only the fetuin 
triantennary peak (Fig. 5). We speculate 
that the first peak of the fetuin oligosac- 
charide represents the molecular species 
with one Neu5Ac(cu2-6)Gal unit ‘and the 
major portion of the retarded fraction 
contains two units of this sequence; further 
structural studies are necessary to support 
this speculation. 
Interaction of gl~coproteins with defined 
Neu5AoGal/GaJNAc sequences with SNA- 
Sepharose. Ovine submaxillary mucin and 
antifreeze glycoprotein derivatives which 
contain defined carbohydrate chains syn- 
thesized in vitro using purified sialyl 
transferases (17, 18) were analyzed using 
the same column (Fig. 6). The ovine 
submaxillary mucin derivative which con- 
tains the Neu5Ac(a2-G)GalNAc-Thr/Ser 
sequence bound tightly to the SNA-Seph- 
arose, whereas the antifreeze glycoprotein 
carrying Neu5Ac(a2-3)Gal(fl1-3)GalNAc- 
Thr/Ser did not bind (data not shown). In- 
terestingly, the antifreeze glycoprotein 
which bears the Neu5Ac(a2-6)GalNAc se- 
quence with side chains attached to the O- 
3 of the subterminal GalNAc did not bind 
to the column (Figs. 6B and C). 
Contribution of the free carboxy group of 
Neu5Ac to the interaction with SNA-Seph- 
arose. We have already shown that the O- 
3 and O-4 hydroxyl groups of Gal residues 
and the C-8 and/or C-9 hydroxyl groups of 
the glyceryl side chain of Neu5Ac are im- 
portant for interaction of the NeuFiAc(aZ- 
6)Gal unit with SNA (14). To determine the 
contribution of free carboxyl groups on the 
Neu5Ac residue, the methyl ester of 
[3H]Neu5Ac(a2-6)lactitol was synthesized 
and applied to the SNA-Sepharose column. 
Neu5Ac(cY2-G)lactitol, which can bind to 
this column (Fig. l), lost its ability to in- 
teract with the column after esterification 
of the carboxyl group of Neu5Ac (Fig. ‘7A). 
The ability of the esterified Neu5Ac to bind 
to the SNA-Sepharose was recovered by 
saponification of the ester (Fig. 7B), show- 
ing the importance of a free carboxyl group 
on Neu5Ac for binding to SNA. 
Application of SNA-Sepharose column to 
the analysis of glycoproteins. Two glyco- 
proteins, bovine fetuin and orosomucoid, 
were applied separately to the immobilized 
SNA to determine the possible use of this 
technique for the analysis of microheter- 
ogeneity in the carbohydrate moiety of 
glycoproteins. As shown in Figs. 8A and B, 
portions of both fetuin and orosomucoid 
bound strongly to the SNA-Sepharose and 
these glycoproteins were separated into 
two fractions which were eluted with lac- 
tose and ethylenediamine, respectively, 
SHIBUYA ET AL. 
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FIG. 4. Separation of porcine thyroglobulin biantennary oligosaccharide and human transferrin 
biantennary glycopeptide by the SNA-Sepharose column. ‘H-labeled thyroglobulin oligosaccharide 
(0) and ‘%-labeled transferrin glycopeptide (0) were mixed and applied to the SNA-Sepharose 
column. Elution was performed with a linear gradient of lactose, and then with 20 mM ethylenediamine 
(EDA). 
suggesting the presence of some types of coprotein molecules. Asialo derivatives of 
microheterogeneity, most possibly due to both glycoproteins passed through the col- 
the different density and distribution of umn (only the elution profile of asialo fe- 
Neu5Ac(a2-6)Gal sequences in these gly- tuin is shown). 
FRACTION NUMBER (50 drops/tube) 
FIG. 5. Separation of human fibrinogen biantennary glycopeptide and porcine fetuin triantennary 
oligosaccharide by the SNA-Sepharose column. ‘H-labeled fetuin oligosaccharide (0) and ‘“C-labeled 
fibrinogen glycopeptide (0) were mixed and applied to the SNA-Sepharose column. Elution was 
performed as described for Fig. 4. 
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FIG. 6. Elution profile of glycoproteins containing 
Neu5Ac(cY2-G)GalNAc-Thr/Ser structure. (A) Ovine 
submaxillary mucin with Neu5Ac(cu2-G)GalNAc-Thr/ 
Ser; (B) antifreeze glycoprotein with NeuBAc(cyZ- 
G)[Gal(Bl-3)]GalNAc-Thr/Ser; (C) antifreeze glyco- 
protein with Neu5Ac(a2-6)[Neu5Ac(a2-3)Gal@l- 
3)]GalNAc-Thr/Ser. All the glycoproteins were first 
desialylated and then resialylated using specific sialyl 
transferases (1’7,lS) and [“‘C]Neu5Ac. 
DISCUSSION 
The results described herein demon- 
strate that immobilized SNA can bind oli- 
- 
(150 drops/tube 1 
FIG. ‘7. Effect of the esterification of the carboxyl 
group of Neu5Ac on the interaction of [aHJNeu5Ac(or2- 
6)lactitol with SNA-Sepharose. (A) Methyl ester of 
rHlNeu5Ac(ol2-6)lactitol; (B) after saponification of 
methyl ester. 
(150 drops/tube) 
FIG. 8. Elution profile of orosomucoid, fetuin, and 
asialofetuin on SNA-Sepharose. (A) orosomucoid; (B) 
fetuin; (C) asialofetuin. 
gosaccharides, glycopeptides, and glyco- 
proteins which possess Neu5Ac(a2-G)Gal/ 
GalNAc sequences, whereas those with 
Neu5Ac(a2-3)GaVGalNAc sequences are 
not bound. This important discovery has 
permitted us to separate clearly, molecular 
species which differ only in the type of 
linkages between terminal Neu5Ac and 
GaVGalNAc residues. The presence of one 
Neu5Ac(a2-6)Gal unit was sufficient to 
permit the binding of oligosaccharides or 
glycopeptides to this column. It is note- 
worthy that even [3HJNeu5Ac(a2-6)lactitol, 
with an association constant (K,) for SNA 
= 3.9 X lo5 M-‘, could bind to the SNA- 
Sepharose, even though Baenziger and 
Fiete reported that glycopeptides with K, 
less than 4 X lo6 M-’ could not bind to Con 
A-Sepharose (19). The immobilized SNA- 
Sepharose column is useful not only to sep- 
arate the 2,6-linked isomers from 2,3-linked 
ones, but also is applicable for the frac- 
tionation of oligosaccharides, glycopep- 
tides, and possibly glycoproteins based on 
their number of Neu5Ac(crZ-6)Gal units 
(Figs. 4, 5, and 8). 
The binding capacity of SNA-Sepharose 
estimated by an overloading experiment 
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was approximately 2-3 nmol/ml; in other 
words, 8-13s of the total carbohydrate 
binding sites of the immobilized SNA were 
active. 
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Branching of side chains from O-3 of the 
subterminal GalNAc residue destroyed the 
capacity of glycoproteins to bind to the 
SNA-Sepharose (Fig. 6). This may be ex- 
plained from the previous finding that the 
free hydroxyl group at O-3 and O-4 of Gal 
(possibly also GalNAc) are critical for the 
binding of SNA, though some steric effect 
also may contribute to this interference. 
The finding that the esterification of car- 
boxy1 group of Neu5Ac residue also abol- 
ished the binding ability of [3Hpeu5Ac(a2- 
6)lactitol gave us further insight regarding 
the interaction of SNA with sialylated oli- 
gosaccharides. In addition to the O-3 and 
O-4 hydroxyl groups of Gal and the C-8, 
the C-9 portion of glyceryl side chain of 
Neu5Ac, free carboxyl groups of Neu5Ac 
also may be involved in the interaction. 
From its unique ability to separate oli- 
gosaccharides, glycopeptides, or glycopro- 
teins based on the type of linkage between 
Neu5Ac and Gal/GalNAc, SNA should be 
a very useful tool for the detection, isola- 
tion, and characterization of these com- 
pounds. 
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